NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research note published on Sunday. The brokerage issued a sell rating on the medical device company’s stock.

NeuroMetrix Stock Down 3.2 %

NASDAQ NURO opened at $3.65 on Friday. The company has a market cap of $7.34 million, a PE ratio of -0.58 and a beta of 2.30. NeuroMetrix has a 52 week low of $2.70 and a 52 week high of $7.94. The firm’s 50-day simple moving average is $3.93 and its two-hundred day simple moving average is $3.73.

NeuroMetrix (NASDAQ:NURO) last announced its quarterly earnings results on Wednesday, May 15th. The medical device company reported ($1.67) EPS for the quarter. NeuroMetrix had a negative net margin of 151.51% and a negative return on equity of 39.85%. The business had revenue of $1.09 million for the quarter.

Hedge Funds Weigh In On NeuroMetrix

An institutional investor recently bought a new position in NeuroMetrix stock. Cerity Partners LLC bought a new stake in shares of NeuroMetrix, Inc. (NASDAQ:NURO) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned approximately 2.80% of NeuroMetrix as of its most recent SEC filing. Hedge funds and other institutional investors own 19.40% of the company’s stock.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.